Compare the Success Rate of T3 Dental Implant (Biomet 3I) With or Without Platform-switch Concept
NCT ID: NCT01971268
Last Updated: 2013-10-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
50 participants
OBSERVATIONAL
2014-01-31
2015-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Two groups were formed: one group received a T3 dental implant with platform switch concept and the other received an implant with platform matched type of connection.
We evaluate osseointegration at T1 (12 weeks) and marginal bone position in relation to the implant platform at baseline (implant installation) T0 and again at T1 and T2.
From data recorder in T0,T1 and T2, we evaluate changes in marginal bone position.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Platform-Switch Group
T3 dental implant, with platform-switch dental implant platform concept, measure marginal bone loss
Dental Implant
place dental implants according to manufacturer guidelines
Platform-Switch Dental Implant
Place Dental Implant with an abutment narrower than the implant platform
Platform-Matched Group
T3 dental implant, platform-matched dental implant platform concept, measure marginal bone loss
Dental Implant
place dental implants according to manufacturer guidelines
Platform-Matched dental implant
Place Dental Implant with abutment with same size as the platform
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dental Implant
place dental implants according to manufacturer guidelines
Platform-Switch Dental Implant
Place Dental Implant with an abutment narrower than the implant platform
Platform-Matched dental implant
Place Dental Implant with abutment with same size as the platform
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Maxilla and mandible
* Biomet 3I T3 dental implant placed
* Final Rehabilitation placed
Exclusion Criteria
* Radiographic impossibility of measure
* Absence of baseline T0 radiograph
* Smoking habits (more 10 cigarets a day)
* Diabetes
* Patients who receive Radio or/and Chemotherapy
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Implantology Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Andre Chen
Mcs
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andre Chen, Msc
Role: PRINCIPAL_INVESTIGATOR
Implantology Institute
João Caramês, Phd
Role: STUDY_DIRECTOR
Implantology Institute
Helena Francisco, Msc
Role: STUDY_CHAIR
Implantology Institute
Elena Cervino, Msc
Role: STUDY_CHAIR
Implantology Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Instituto de Implantologia
Lisbon, Lisbon District, Portugal
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Joana Velez
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
II-02
Identifier Type: -
Identifier Source: org_study_id